Dr. Tony Holohan:

Regarding the licensing question, the potential costs and so on, I would only be speculating if I was to answer the question. I do not have the expertise to make a speculation on that. Some of the medicines are already in use in the State but for other purposes. Whether that would have any bearing on what would ultimately be commercial decisions, I cannot say. In respect of the next question, perhaps Dr. McKenna would like to offer a view.